Journal of Drugs in Dermatology Highlights Data Showing the Benefits of Solubilized 5% Benzoyl Peroxide Gel in the ... (Centre Daily Times)

Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today the publication of a study of its solubilized 5% BPO gel in the June 2008 issue of Journal of Drugs in Dermatology. When compared to twice-daily treatment with a leading BPO/clindamycin antibiotic combination product, the twice-daily monotherapy with the solubilized 5% ...